Validation of COPDPredict™: Unique Combination of Remote Monitoring and Exacerbation Prediction to Support Preventative Management of COPD Exacerbations

References

• Suissa S, Dell’Aniello S, Ernst P, et al. Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality. Thorax. 2012;67(11):957–963. doi:10.1136/thoraxjnl-2011-201518 PMID: 22684094.
   PubMed Web of Science ®Google Scholar
• Rothnie KJ, Mullerova H, Smeeth L, Quint JK. Natural history of chronic obstructive pulmonary disease exacerbations in a general practice-based population with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2018;198:464–471. doi:10.1164/rccm.201710-2029OC
   PubMed Web of Science ®Google Scholar
• Han MK, Quibrera PM, Carretta EE, et al. Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort. Lancet Respir Med. 2017;5(8):619–626. doi:10.1016/S2213-2600(17)30207-2
   PubMed Web of Science ®Google Scholar
• Hoogendoorn M, Feenstra TL, Boland M, et al. Prediction models for exacerbations in different COPD patient population: comparing results from five large data sources. Int J Chron Obstruct Pulmon Dis. 2017;12:3138–3194. doi:10.2147/COPD.S142378
   Web of Science ®Google Scholar
• Bollmeier SG, Hartmann AP. Management of chronic obstructive pulmonary disease: a review focusing on exacerbations. Am J Health-System Pharmacy. 2020;77(4):259–268. doi:10.1093/ajhp/zxz306
   PubMed Web of Science ®Google Scholar
• Hurst JR, Vestbo J, Anzueto A, et al. Evaluation of COPD longitudinally to identify predictive surrogate endpoints (ECLIPSE) Investigators. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363(12):1128–1138. doi:10.1056/NEJMoa0909883
   PubMed Web of Science ®Google Scholar
• Patel JG, Coutinho AD, Lunacsek OE, Dalal AA. COPD affects worker productivity and health care costs. Int J Chron Obstruct Pulmon Dis. 2018;13:2301–2311. doi:10.2147/COPD.S163795
   PubMed Web of Science ®Google Scholar
• Quaderi SA, Hurst JR. The unmet global burden of COPD. Glob Health Epidemiol Genom. 2018;3:e4. doi:10.1017/gheg.2018.1
   PubMed Web of Science ®Google Scholar
• Kong CW, Wilkinson TMA. Predicting and preventing hospital readmission for exacerbations of COPD. ERJ Open Res. 2020;6:00325–2019. doi:10.1183/23120541.00325-2019
   PubMedGoogle Scholar
• Halpin DM, Miravitlles M, Metzdorf N, Celli B. Impact and prevention of severe exacerbations of COPD: a review of the evidence. Int J Chron Obstruct Pulmon Dis. 2017;12:2891–2908. doi:10.2147/COPD.S139470
   PubMed Web of Science ®Google Scholar
• Punekar YS, Shukla A, Mullerova H. COPD management costs according to the frequency of COPD exacerbations in UK primary care. Int J Chron Obstruct Pulmon Dis. 2014;9:65–73. doi:10.2147/COPD.S54417
   PubMed Web of Science ®Google Scholar
• McAuley H, Hadley K, Elneima O, et al. COPD in the time of COVID-19: an analysis of acute exacerbations and reported behavioural changes in patients with COPD. ERJ Open Res. 2021;7:00718–2020. doi:10.1183/23120541.00718-2020
   PubMedGoogle Scholar
• Xu W, Collet JP, Shapiro S, et al. Negative impacts of unreported COPD exacerbations on health-related quality of life at 1 year. Eur Respir J. 2010;35(5):1022–1030. doi:10.1183/09031936.00079409
   PubMed Web of Science ®Google Scholar
• Bucknall CE, Miller G, Lloyd SM, et al. Glasgow supported self-management trial (GSuST) for patients with moderate to severe COPD: randomised controlled trial. BMJ. 2012;344:e1060. doi:10.1136/bmj.e1060
   PubMed Web of Science ®Google Scholar
• Bischoff EW, Hamd DH, Sedeno M, et al. Effects of written action plan adherence on COPD exacerbation recovery. Thorax. 2011;66(1):26–31. doi:10.1136/thx.2009.127621
   PubMed Web of Science ®Google Scholar
• Keesara S, Jonas A, Schulman K. Covid-19 and Health care’s Digital Revolution. N Engl J Med. 2020;382(23):e82. doi:10.1056/NEJMp2005835
   PubMed Web of Science ®Google Scholar
• Wilkinson TM, Donaldson GC, Hurst JR, Seemungal TA, Wedzicha JA. Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004;169(12):1298–1303. doi:10.1164/rccm.200310-1443OC
   PubMed Web of Science ®Google Scholar
• National Institute of Clinical Excellence (NICE). Chronic obstructive pulmonary disease: management in adults in primary and secondary care; June 2010. Available from: www.nice.org.uk/CG101. Accessed June 2, 2021.
   Google Scholar
• Hurst JR, Donaldson GC, Quint JK, et al. Temporal clustering of exacerbations in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2009;179:369–374. doi:10.1164/rccm.200807-1067OC
   PubMed Web of Science ®Google Scholar
• Cochrane review self management interventions; August 2017. Available from: https://www.cochrane.org/CD011682/AIRWAYS_self-management-interventions-including-action-plans-patients-chronic-obstructive-pulmonary-disease. Accessed June 2, 2021.
   Google Scholar
• Velardo C, Shah SA, Gibson O, et al. Digital health system for personalised COPD long-term management. BMC Med Inform Decis Mak. 2017;17(1):19. doi:10.1186/s12911-017-0414-8
   PubMed Web of Science ®Google Scholar
• Boer LM, van der Heijden M, van Kuijk NM, et al. Validation of ACCESS: an automated tool to support self-management of COPD exacerbations. Int J Chron Obstruct Pulmon Dis. 2018;13:3255–3267. doi:10.2147/COPD.S167272
   PubMed Web of Science ®Google Scholar
• Guerra B, Gaveikaite V, Bianchi C, Puhan MA. Prediction models for exacerbations in patients with COPD. Eur Respir Rev. 2017;26(143):160061. doi:10.1183/16000617.0061-2016
   PubMed Web of Science ®Google Scholar
• Patel N, Belcher J, Thorpe G, et al. Measurement of C-reactive protein, procalcitonin and neutrophil elastase in saliva of COPD patients and healthy controls: correlation to self-reported wellbeing parameters. Respir Res. 2015;16:62. doi:10.1186/s12931-015-0219
   PubMed Web of Science ®Google Scholar
• Spiteri M. Analyser apparatus and methods for lung disease. US8812249 B2; 19 August 2014. Available from: https://patents.google.com/patent/US8812249. Accessed June 2, 2021.
   Google Scholar
• The 2020 global strategy for the prevention, diagnosis and management of chronic obstructive lung disease (COPD). Available from: https://goldcopd.org/gold-reports/. Accessed June 2, 2021.
   Google Scholar
• Le Rouzic O, Roche N, Cortot AB, et al. Defining the “frequent exacerbator” phenotype in COPD: a hypothesis-free approach. Chest. 2018;153(5):1106–1115. doi:10.1016/j.chest.2017.10.009
   PubMed Web of Science ®Google Scholar
• Walters JAE, Tan DJ, White CJ, Wood-Baker R. Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease (Review). Cochrane Database Syst Rev. 2018;3:. doi:10.1002/14651858.CD006897.pub4
   Web of Science ®Google Scholar
• Stolbrink M, Amiry J, Blakey JD. Does antibiotic treatment duration affect the outcomes of exacerbations of asthma and COPD? A systematic review. Chron Respir Dis. 2018;15(3):225–240. doi:10.1177/1479972317745734
   PubMed Web of Science ®Google Scholar
• Singh D, Agusti A, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019. Eur Respir J. 2019;53(5):1900164. doi:10.1183/13993003.00164-2019
   PubMed Web of Science ®Google Scholar
• Mackay AJ, Donaldson GC, Patel AR, et al. Detection and severity grading of COPD exacerbations using the exacerbations of chronic pulmonary disease tool (EXACT). Eur Respir J. 2014;43(3):735–744. doi:10.1183/09031936.00110913
   PubMed Web of Science ®Google Scholar
• Pinnock H, Hanley J, McCloughan L, et al. Effectiveness of telemonitoring integrated into existing clinical services on hospital admission for exacerbation of chronic obstructive pulmonary disease: researcher blind, multicentre, randomised controlled trial. BMJ. 2013;347:f6070. doi:10.1136/bmj.f6070
   PubMed Web of Science ®Google Scholar
• Zhang Y, Morgan RL, Alonso-Coella P, et al. A systemic review of how patients value COPD outcomes. Eur Respir J. 2018;52:1800222. doi:10.1183/13993003.00222-2018
   PubMedGoogle Scholar
• Criner GJ, Bourbeau J, Diekemper RL, et al. Prevention of acute exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline. Chest. 2015;147(4):894–942.
   PubMed Web of Science ®Google Scholar
• Pinnock H, Steed L, Jordan R. Supported self-management for COPD: making progress, but there are still challenges. Eur Respir J. 2016;48(1):6–9.
   PubMed Web of Science ®Google Scholar
• Cruz J, Brooks D, Marques A. Home telemonitoring in COPD: a systematic review of methodologies and patients’ adherence. Int J Med Inform. 2014;83(4):249–263. doi:10.1016/j.ijmedinf.2014.01.008
   PubMed Web of Science ®Google Scholar
• Patel N. Chronic obstructive pulmonary disease patients’ experiences of an enhanced self-management model of care. Qual Health Res. 2015;26:568–577. doi:10.1177/104973231557301
   PubMed Web of Science ®Google Scholar
• Lenferink A, Brusse-Keizer M, van der Valk P, et al. Self-management interventions including action plans for exacerbations versus usual care in patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2017;8:CD011682. doi:10.1002/14651858.CD011682.pub2
   PubMed Web of Science ®Google Scholar
• Butler CC, Gillespie D, White P, et al. C-Reactive protein testing to guide antibiotic prescribing for COPD exacerbations. N Eng J Med. 2019;381(2):111–120. doi:10.1056/NEJMoa1803185
   PubMed Web of Science ®Google Scholar
• Wakeman M, Cork T, Watwood D. Point-of-care C-reactive testing in community pharmacy to deliver appropriate interventions in respiratory tract infections. Clinical Pharmacist. 2018;10(5):10. doi:10.1211/PJ.2018.20204635
   Google Scholar
• Shah SA, Velardo C, Farmer A, Tarassenko L. Exacerbations in chronic obstructive pulmonary disease: identification and prediction using a digital health system. J Med Internet Res. 2017;19(3):e69. doi:10.2196/jmir.7207
   PubMed Web of Science ®Google Scholar
• Adibi A, Sin DD, Safari A, et al. The Acute COPD Exacerbation Prediction Tool (ACCEPT): a modelling study. Lancet Respir Med. 2020;8(10):1013–1021. doi:10.1016/S2213-2600(19)30397-2
   PubMed Web of Science ®Google Scholar